Key Record Dates
ClinicalTrials.gov Identifier: | NCT04846478 |
---|---|
Brief Title: | Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC |
First Submitted : | April 13, 2021 |
First Submitted that Met QC Criteria : | April 13, 2021 |
First Posted : | April 15, 2021 |
Last Update Submitted that Met QC Criteria : | April 25, 2024 |
Last Update Posted : | April 26, 2024 |